SPI-1005 Treatment in Moderate COVID-19 Patients

NCT04484025 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19
Corona Virus Infection
Coronavirus
Coronavirus Infection

Interventions

DRUG: Ebselen
DRUG: Placebo

Sponsor

Sound Pharmaceuticals, Incorporated